Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Acta Biomaterialia|January 12, 2020
Newly formed and remodeled human bone exhibits differences in the mineralization processAndreas Roschger, Wolfgang Wagermaier, Sonja Gamsjaeger, et al.
British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.
Applied and Environmental Microbiology|February 5, 2005
Propionate oxidation by and methanol inhibition of anaerobic ammonium-oxidizing bacteriaDidem Güven, Ana Dapena, Boran Kartal, et al.
Future Science OA|October 9, 2025
Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial ProtocolSebastian Theurich, Timo Niels, Hansjoerg Baurecht, et al.
Haematologica|May 13, 2017
Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantationMaximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 17, 2017
Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in BoneCaressa D Lietman, Joohyun Lim, Ingo Grafe, et al.
JAMA|January 18, 2007
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trialHelmut Oettle, Stefan Post, Peter Neuhaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalitiesStefan Gröschel, Sanne Lugthart, Richard F Schlenk, et al.
Cell Reports|May 11, 2021
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilitiesManuel Hayn, Maximilian Hirschenberger, Lennart Koepke, et al.
Haematologica|January 2, 2008
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myelomaHenk M Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, et al.
Pageof 8